Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fidelity National Information Servcs Inc (FIS) vs Tilray Brands Inc (TLRY) Price & Performance

Fidelity National Information Servcs IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Fidelity National Information Servcs Inc vs Tilray Brands Inc — how do they compare? Fidelity National Information Servcs Inc trades at $34.16 (market cap $17.71B), while Tilray Brands Inc trades at $3.42 (market cap $530.54M). The key difference: Fidelity National Information Servcs Inc is far larger — about 33.4× Tilray Brands Inc's market cap, and Fidelity National Information Servcs Inc pays a 5.13% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fidelity National Information Servcs Inc for 88 Days and Tilray Brands Inc for 31 Days on average.

FISTLRY
Market Cap
$17.71B$530.54M
Volume
9,047,8259,099,075
Sector
TechnologyHealth
52-Week High
$68.57$21.00
52-Week Low
$32.44$3.57
Typical Hold Time
88 Days31 Days
Enterprise Value
$38.22B$684.46M
Dividend Yield
5.13%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fidelity National Information Servcs Inc

FIS trades at $33.82, up 1.2% today, with a bearish technical signal despite beating earnings estimates in two of the last three quarters. The stock shows attractive valuation metrics with a P/E of 5.27 and P/S of 1.46, while analyst consensus remains strongly bullish with a $47.15 price target. Recent business developments include multiple core banking platform wins and new embedded banking offerings, signaling growth momentum in financial technology services.

The outlook appears positive given FIS's improving profitability trajectory and strong analyst support, though investors should monitor debt levels and execution risks. With revenue projected to grow to $12.2B in 2026 and net income margin expanding to 27.64%, the stock offers fundamental upside potential if the company can maintain its competitive positioning in banking technology modernization.

Tilray Brands Inc

TLRY trades at $3.465, down 6.73% on the day and near 52-week lows, reflecting persistent bearish sentiment. The stock shows weak technical momentum with oversold RSI readings but faces fundamental challenges including consecutive quarterly earnings misses, negative profit margins, and declining revenue growth. Recent news highlights the company's struggles with profitability despite record annual revenue, with shares down over 50% year-to-date as investors question the cannabis company's path to sustainable growth.

TLRY presents a high-risk opportunity with significant downside protection from its low P/B ratio of 0.33, but requires substantial operational improvement to justify investment. The bullish case hinges on potential marijuana reform catalysts and BrewDog integration progress, while risks include ongoing losses, competitive pressures, and execution challenges in a volatile regulatory environment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FIS
76% Buy24% Sell
Avg holding period · 88 Days
TLRY
100% Buy0% Sell
Avg holding period · 31 Days

Top news

Latest headlines on both assets

About Fidelity National Information Servcs Inc

Fidelity National Information Services' legacy operations provide core and payment processing services to banks, but its business has expanded over time. By acquiring Sungard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS now provides payment processing services for merchants and holds leading positions in the United States and United Kingdom. About a fourth of revenue is generated outside North America.

Read more on FIS →

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →